Skip to main navigation
Dynavax
  • Overview
  • News & Events
    • Press Releases
    • Events & Presentations
  • Stock Information
    • Stock Quote & Chart
    • Analyst Coverage
  • Corporate Governance and Compliance
    • Corporate Governance
    • Board of Directors
    • Committee Composition
    • Contact the Board
  • Financials
    • Overview
    • SEC Filings
    • Annuals and Proxies
  • Investor Contact

Annuals and Proxies

2023 Proxy Statement and 2022 Annual Report
Additional proxy soliciting materials - definitive

Footer Links - Column 1

  • About
  • Overview
  • Management
  • Board of Directors
  • Dynavax Europe

Footer Links - Column 2

  • Science
  • Overview
  • Publications & Presentations
  • CpG 1018

Footer Links - Column 3

  • Careers
  • Join Our Team
  • Values
  • Job Opportunities
  • Benefits

Footer Links - Column 4

  • Investors
  • Overview
  • News & Events
  • Stock Information
  • Financials
  • Contact Us

Footer Links - Column 5

  • Product
  • HEPLISAV-B

Footer Links - Column 6

  • Pipeline
  • Clinical Trials

Footer Links - Column 7

  • Contact
  • Investor Contact

    Nicole Arndt
    Investor Relations
    narndt@dynavax.com

  • Terms & Conditions
  • Privacy Notice
  • © 2023 Dynavax Technologies Corporation. All rights reserved.